TABLE 2.

Main components of LDL(-), HDL, and apoAI in native state and after treatements

	LDL(–)
	Untreated	After HDL	After apoAI
%CT	42.2 ± 1.7	41.8 ± 2.0	42.3 ± 2.5
%TG	9.4 ± 1.2	9.4 ± 1.3	9.6 ± 1.1
%PL	27.1 ± 2.9	27.5 ± 3.2	27.8 ± 3.5
%ApoB	21.3 ± 1.1	21.3 ± 1.0	20.3 ± 1.6
%ApoAI	ND	ND	ND

	HDL		apoAI
	Untreated	After LDL(–)	Untreated	After LDL(–)
%CT	18.5 ± 2.2	18.4 ± 1.1	0.03 ± 0.05	1.39 ± 0.59*
%TG	4.6 ± 3.3	4.1 ± 0.8	ND	1.35 ± 1.59
%PL	34.8 ± 3.6	34.5 ± 3.8	0.53 ± 0.61	5.84 ± 1.69*
%ApoAI	42.1 ± 4.6	43.0 ± 3.6	99.4 ± 0.6	91.42 ± 1.64*
%ApoB	ND	ND	ND	ND

The amount of each component is expressed as % of mass. The table shows composition of LDL(–) in native state and preincubated with HDL and apoAI in 1:1 proporation (being 1 = 0.5 g apoB/L of LDL and 0.5g apoAI/L of HDL). It also shows composition of HDL and apoAI in native state and preincubated with LDL(–) in 1:1 proportion. CT, cholesterol; TG, triglyceride; PL, phospholipids; ND, nondetectable; n = 9 except for apoAI (n = 4). Significant differences with P = 0.068 are indicated with * versus native state.